📊 CDTTW Key Takeaways
Investment Thesis
CDT Equity is a pre-revenue pharmaceutical company with severe cash burn and negative profitability across all metrics. The company is burning approximately $11.3M in free cash flow annually with only $3.8M in cash reserves, creating a critical runway issue without additional financing.
CDTTW Strengths
- Modest long-term debt of only $200K limiting leverage risk
- Current ratio of 1.66x indicates adequate short-term liquidity
- Pharmaceutical sector positioning if clinical/regulatory milestones achieved
CDTTW Risks
- No revenue generation with complete dependence on cash reserves for operations
- Negative free cash flow of -$11.3M annually with only ~10 months of cash runway remaining
- Extreme negative returns (ROE -418.4%, ROA -209.3%) and operating margin of N/A indicating losses on minimal asset base
- Operating losses of -$15.6M and net losses of -$17.9M with deteriorating EPS
- Pre-clinical/early-stage status with no clear path to revenue or profitability
Key Metrics to Watch
- Monthly cash burn rate and runway to profitability or capital raise
- Clinical trial progress and regulatory milestones
- Insider buying/selling activity for signal of management confidence
- Operating loss trends and ability to extend cash runway
CDTTW Financial Metrics
💡 AI Analyst Insight
CDT Equity Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
CDTTW Profitability Ratios
CDTTW vs Healthcare Sector
How CDT Equity Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CDTTW Balance Sheet & Liquidity
CDTTW 5-Year Financial Trend
5-Year Trend Summary: CDT Equity Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-8.92 indicates the company is currently unprofitable.
CDTTW Growth Metrics (YoY)
CDTTW Capital Allocation
CDTTW SEC Filings
Access official SEC EDGAR filings for CDT Equity Inc. (CIK: 0001896212)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CDTTW
What is the AI rating for CDTTW?
CDT Equity Inc. (CDTTW) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CDTTW's key strengths?
Modest long-term debt of only $200K limiting leverage risk. Current ratio of 1.66x indicates adequate short-term liquidity.
What are the risks of investing in CDTTW?
No revenue generation with complete dependence on cash reserves for operations. Negative free cash flow of -$11.3M annually with only ~10 months of cash runway remaining.
What is CDTTW's revenue and growth?
CDT Equity Inc. reported revenue of N/A.
Does CDTTW pay dividends?
CDT Equity Inc. does not currently pay dividends.
Where can I find CDTTW SEC filings?
Official SEC filings for CDT Equity Inc. (CIK: 0001896212) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CDTTW's EPS?
CDT Equity Inc. has a diluted EPS of $-74.92.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.